Skip to main content
. Author manuscript; available in PMC: 2012 Aug 13.
Published in final edited form as: Autoimmunity. 2009 Sep;42(6):515–524. doi: 10.1080/08916930902911738

Table I.

Clinical characteristics of 57 patients diagnosed with primary SjS and 25 healthy volunteers.

SjS (n = 57) NV (n = 25)
Age, years (mean, ± SD) 53 (± 13) 48 (± 14)
Percent Female 83% 60%
Unstimulated Salivary Flow, mL/15 min (mean, ± SD) 1.30 (± 2.30) 3.39 (± 3.39)
Focus Score* (mean, ± SD) 4 (± 4) 0 (± 1)
Schirmer’s test, mm/5 min (mean, ± SD) 5 (± 7) 14 (± 11)
Anti-SSA positive by ELISA (%) 72 0
Anti-SSB positive by ELISA (%) 46 0
RF positive (%) 60 8
ESR, mm/h (mean, ± SD) 27 (± 26) 16 (± 13)
Serum IgG, mg/dL (mean, ± SD) 1640 (± 857) 1162 (± 291)
*

Minor salivary gland biopsy and focus score data was available for all subjects. A focus score of 1 or greater is needed to show histopathological evidence of Sjögren’s syndrome.;

Anti-SSA and SSB reference (0–19 EU).;

Rheumatoid Factor reference (< 20 IU/mL).